M. Munzer

发表

Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: Low incidence of CNS tumours

Y. Bertrand, J. van der Werff Ten Bosch, A. Uyttebroeck, 2011, Pediatric blood & cancer.

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.

Y. Bertrand, F. Méchinaud, S. Suciu, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951

H. Cavé, P. Rohrlich, Y. Bertrand, 2017, Haematologica.

Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE)

T. Leblanc, J. Stéphan, O. Oberlin, 2012, British journal of haematology.

Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia

D. Hémon, L. de Lumley, F. Millot, 2004, British Journal of Cancer.

Risk adapted chemotherapy for localised Ewing's sarcoma of bone: the French EW93 study.

B. Bui, O. Oberlin, J. Michon, 2012, European journal of cancer.

Long-term side effects of radiotherapy for pediatric localized neuroblastoma

D. Haas-Kogan, L. Claude, A. Laprie, 2015, Strahlentherapie und Onkologie.

University of Birmingham Risk of second bone sarcoma following childhood cancer

J. Benichou, D. Lefkopoulos, P. Bondiau, 2014 .

Familial history of cancer and childhood acute leukemia: a French population-based case–control study

F. Menegaux, L. de Lumley, F. Millot, 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers.

M. Polak, P. Czernichow, D. Kariyawasam, 2011, JAMA.

Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

M. Schluchter, J. Goedert, P. Boisse, 2001, AIDS.

Rituximab therapy for childhood Evans syndrome

A. Pariente, C. Picard, F. Ledeist, 2007, Haematologica.

Lymphocyte data in Epstein–Barr‐virus induced post‐transplant lymphoproliferative disorder treated by rituximab

N. Entz-Werlé, P. Lutz, D. Eyer, 2003, Pediatric transplantation.

Detection of N‐myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR

J. Zahm, P. Birembaut, V. Combaret, 2002, The Journal of pathology.

Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study

K. Hoang-Xuan, C. Garel, A. Idbaih, 2011, Orphanet journal of rare diseases.

Improved outcome with pulses of Vincristine (VCR) and Steroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and Non Hodgkin Lymphoma (NHL): final report of the EORTC randomized phase III trial 58951

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2008 .

Deficit in anterior pituitary function and variable immune deficiency (DAVID) in children presenting with adrenocorticotropin deficiency and severe infections.

R. Jaussaud, A. Barlier, B. Delemer, 2012, The Journal of clinical endocrinology and metabolism.

Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children

P. Nguyên, P. Pouzol, P. François, 1994, European Journal of Pediatrics.

Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience

G. Leverger, P. Rohrlich, T. Leblanc, 2012 .

Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.

Y. Bertrand, J. Donadieu, C. Vermylen, 2005, European journal of cancer.

Long-term evaluation of Ifosfamide-related nephrotoxicity in children.

G. Leverger, D. Orbach, P. Niaudet, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Y. Bertrand, A. Uyttebroeck, B. De Moerloose, 2010, Blood.

lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results Hyperdiploidy with 58-66 chromosomes in childhood B-acute

F. Speleman, H. Cavé, Y. Bertrand, 2013 .

[Pitfalls of hematopoietic growth factors on MR images].

C. Béhar, M. Munzer, H. Gomes, 2002, Journal de radiologie.

Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.

K. Baumstarck, P. Moreau, T. Lambert, 2021, The Journal of pediatrics.

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

P. Maes, Y. Bertrand, J. van der Werff Ten Bosch, 2005, Leukemia.

Inherited MST1 Deficiency Underlies Susceptibility to EV-HPV Infections

A. Fischer, J. Casanova, C. Picard, 2012, PloS one.

[Cutaneous granulomatous lesions disclosing ataxia-telangiectasia].

J. Motte, M. Munzer, E. Grosshans, 1999, Annales de dermatologie et de venereologie.

Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey

A. Fischer, C. Bodemer, J. Casanova, 2012, Medicine.

Rhabdomyosarcomas in children with neurofibromatosis type I: A national historical cohort

D. Orbach, J. Stéphan, S. Sarnacki, 2015, Pediatric blood & cancer.

Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations

C. Bellanné-Chantelot, S. Beaufils, J. Donadieu, 2014, Pediatric blood & cancer.

Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial

H. Cavé, N. Dastugue, A. Uyttebroeck, 2014, Haematologica.

Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment

J. Benichou, D. Lefkopoulos, P. Bondiau, 2014, Radiation and Environmental Biophysics.

A 22-year French Experience with Solid Tumors in Children with Down Syndrome

A. Sasco, A. Chompret, D. Lacombe, 2003, Pediatric hematology and oncology.

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results.

F. Speleman, H. Cavé, P. Rohrlich, 2013, Blood.

Dexamethasone (DEX) versus prednisone (PRED) in T-cell non Hodgkin lymphoma (T-NHL): results of the randomized phase III trial 58951 of the EORTC Children Leukemia Group

P. Rohrlich, Y. Bertrand, A. Uyttebroeck, 2012 .

Clinical and molecular variability in congenital dyserythropoietic anaemia type I

H. Tamary, I. Yaniv, B. Bader-Meunier, 2005, British journal of haematology.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

F. Rieux-Laucat, A. Fischer, J. Jais, 2019, Journal of Clinical Immunology.

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

F. Rieux-Laucat, A. Fischer, J. Jais, 2017, The Journal of allergy and clinical immunology.

[Kaposiform haemangioendothelioma associated with B-cell acute lymphoblastic leukemia].

F. Grange, P. Bernard, M. Munzer, 2013, Annales de dermatologie et de vénéréologie.

Transient remission of childhood acute lymphoblastic and myeloid leukemia without any cytostatic treatment: 2 case reports and a review of literature.

M. Abély, M. Munzer, P. Mauran, 2015, Journal of pediatric hematology/oncology.

Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience

G. Leverger, P. Lutz, C. Munzer, 2014, British journal of haematology.

[Transfusion in palliative care in child with malignant disease].

M. Munzer, 2010, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Thyroid Radiation Dose and Other Risk Factors of Thyroid Carcinoma Following Childhood Cancer.

D. Lefkopoulos, P. Bondiau, M. Schlumberger, 2015, The Journal of clinical endocrinology and metabolism.

The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer

P. Bondiau, A. Dumas, F. de Vathaire, 2018, European journal of heart failure.

Cardiac Diseases Following Childhood Cancer Treatment: Cohort Study

X. Jouven, P. Bondiau, S. Koscielny, 2016, Circulation.

Risk of subsequent colorectal cancers after a solid tumor in childhood: Effects of radiation therapy and chemotherapy

P. Bondiau, A. Dumas, C. Rubino, 2018, Pediatric blood & cancer.

Thyroid adenomas after solid cancer in childhood.

D. Lefkopoulos, P. Bondiau, M. Schlumberger, 2012, International journal of radiation oncology, biology, physics.

Head and neck presentations of B‐NHL and B‐AL in children/adolescents: Experience of the LMB89 study

A. Baruchel, G. Leverger, C. Patte, 2014, Pediatric blood & cancer.

Clinical and Laboratory Manifestations of Congenital Dyserythropoietic Anemia Type I in a Cohort of French Children

G. Leverger, T. Leblanc, B. Bader-Meunier, 2005, Journal of pediatric hematology/oncology.

P. Rohrlich, Y. Bertrand, A. Uyttebroeck, 2011 .

Risk of second bone sarcoma following childhood cancer: role of radiation therapy treatment

D. Lefkopoulos, P. Bondiau, C. Teinturier, 2014, Radiation and environmental biophysics.

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

H. Cavé, P. Rohrlich, Y. Bertrand, 2012 .

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2010 .

Y. Bertrand, A. Uyttebroeck, B. De Moerloose, 2010, Blood.

Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

Y. Bertrand, A. Uyttebroeck, S. Suciu, 2008 .

Dexamethasone(DEX)(6mg/sm/d) and Prednisolone(PRED)(60mg/sm/d) in Induction Therapy of Childhood ALL Are Equally Effective: Results of the 2nd Interim Analysis of EORTC Trial 58951

A. Baruchel, P. Rohrlich, Y. Bertrand, 2008 .

[Ifosfamide induced encephalopathy: 15 observations].

A. Paci, J. Grill, P. Sabouraud, 2006, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.